Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
08/15/2007 | EP1817336A2 Auristatins having an aminobenzoic acid unit at the n terminus |
08/15/2007 | EP1817328A2 New peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
08/15/2007 | EP1817327A1 Antigenic epitopes of interleukin-21, related antibodies and their use in medical field |
08/15/2007 | EP1108023B1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
08/15/2007 | EP0876610B1 A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility |
08/15/2007 | CN1331884C Corn protein powder polypeptide for suppressing weed germination and rootage, and its separation method and uses |
08/15/2007 | CN1331882C Peptide of decreasing blood pressure of protein of acetes chinensis, preparing method and application |
08/15/2007 | CN101018854A Novel strains belonging to the genus paenibacillus and method of controlling plant disease by using these strains or culture thereof |
08/15/2007 | CN101018564A Treatment of atherosclerosis |
08/15/2007 | CN101016332A Short peptide for inhibiting Shiga toxin and application thereof |
08/15/2007 | CN101015679A Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
08/14/2007 | US7256257 Pentapeptide compounds and uses related thereto |
08/14/2007 | US7256043 Transfection complexes |
08/14/2007 | US7256012 Bioassay; immunoassay; fluorescent dyes binds flexible peptide; self-quenching |
08/14/2007 | US7255861 Preparations for inducing immunotolerance and uses therefor |
08/14/2007 | CA2394572C Fusion protein having enhanced in vivo activity of erythropoietin |
08/14/2007 | CA2223176C Novel kappa receptor selective opioid peptides |
08/09/2007 | WO2007090194A2 Lymphatic zip codes in tumors and pre-malignant lesions |
08/09/2007 | WO2007090022A2 Novel compounds for targeting endothelial cells, compositions containing the same and methods for their use |
08/09/2007 | WO2007089601A2 Nogo receptor antagonists |
08/09/2007 | WO2007088830A1 Novel peptide and therapeutic agent for endotoxin-induced disease using the same |
08/09/2007 | WO2007087851A2 Method for producing epitomers and their uses on carrier microorganisms |
08/09/2007 | WO2007087679A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor v |
08/09/2007 | WO2007061850A3 Methods and systems for generating and evaluating peptides |
08/09/2007 | WO2007028969A3 Anchoring disruption molecules |
08/09/2007 | US20070185311 Peptide-Based Multimeric Targeted Contrast Agents |
08/09/2007 | US20070185034 acetyl-sarcosyl-glycyl-valyl-D-allo-isolucinyl-threoninyl-norvalyl-isolucinyl-arginyl-prolinyl-carboxylic acid; angiogensis inhibitors; anticancer agents |
08/09/2007 | US20070185031 Reducing polyglutamine-based aggregation |
08/09/2007 | US20070185028 Compositions and methods for treatment of protein misfolding and protein aggregation diseases |
08/09/2007 | US20070185027 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
08/09/2007 | US20070185025 Filoviral immunosuppressive peptides and uses thereof |
08/09/2007 | US20070185023 Developmental peptide; drug screening; cancer |
08/09/2007 | US20070184522 Cell death modulation via antagonists of Fasl and Fas activation |
08/09/2007 | US20070184516 Method for the poduction of cyclic molecules |
08/09/2007 | US20070184509 Using variation in reporter expression as assay for monitoring kinase and/or phosphatase activity |
08/09/2007 | US20070184488 Beta-secretase substrates and uses thereof |
08/09/2007 | US20070184487 Compositions and methods for design of non-immunogenic proteins |
08/09/2007 | US20070184064 Chimeric peptide immunogens |
08/09/2007 | US20070183977 RGD peptide sequence; labelled with fluorescein used as contrast agents in optical imaging in diagnosis of angiogenesis-related diseases; peptidic vector and the fluorescein dye are coupled; cyclic peptide forming disulife or monothioether bridge |
08/09/2007 | CA2640423A1 Nogo receptor antagonists |
08/09/2007 | CA2638807A1 Lymphatic zip codes in tumors and pre-malignant lesions |
08/09/2007 | CA2638761A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor v |
08/08/2007 | EP1816138A1 Cyclosporine analogue mixtures and their use as immunomodulating agents |
08/08/2007 | EP1816137A1 Adsorbent adsorbing antibody against 1 adrenoreceptor |
08/08/2007 | EP1816136A1 Gpr7-selective ligand and use thereof |
08/08/2007 | EP1814902A1 New cyclic peptide compound |
08/08/2007 | EP1814901A1 Citrulline peptides derived from fibrin and recognised by rheumatoid arthritis specific autoantibodies and the use thereof |
08/08/2007 | EP1532142A4 Polypeptide cleavage process |
08/08/2007 | EP1507508B1 Composition containing a peptide and a pigment and the use thereof in darkening the skin |
08/08/2007 | EP1456382B1 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
08/08/2007 | EP1100816B1 Aerothricin analogs, their preparation and use |
08/08/2007 | EP0843516B1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits |
08/08/2007 | CN101014314A Peptide-based body surface reagents for personal care |
08/08/2007 | CN101012274A Rana grahami peptide, gene thereof and application in pharmacy |
08/08/2007 | CN101012273A Rana grahami secretory peptide, gene thereof and application in pharmacy |
08/08/2007 | CN101012272A Halobios oxidation resistance active peptide |
08/07/2007 | US7253254 Polypeptide variants with increased heparin-binding capacity |
08/07/2007 | US7253207 Quinones as disease therapies |
08/07/2007 | US7253146 Biopolymer compounds for prevention and treatment of cell proliferative, respiratory system, viral and microbial disorders; antitumor/antiprolifefrative agents; disenfectants |
08/07/2007 | US7253143 For treatment of urinary tract infections and inflammations, colitis, and candida infections of mucosal membranes; infant formula food containing the peptide |
08/07/2007 | US7252827 Fusion protein comprising an immunogenic polypeptide; treatment of Hepatitis CVirus infection and assays for the diagnosis of HCV |
08/07/2007 | US7252825 MAGE-3 peptides presented by HLA class II molecules |
08/07/2007 | US7252815 using carbocyanine dye; photodynamic therapy; supplying to tumor |
08/07/2007 | CA2373252C Long lasting anti-angiogenic peptides |
08/07/2007 | CA2301799C Novel conjugates of opioids and endogenous carriers |
08/07/2007 | CA2246378C Isolation and use of sh3 binding peptides |
08/07/2007 | CA2239702C Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
08/02/2007 | WO2007086932A2 Prostate stem cell antigen vaccines and uses thereof |
08/02/2007 | US20070179278 HIV fusion inhibitor peptides with improved biological properties |
08/02/2007 | US20070179097 GnRH agonist combination drugs |
08/02/2007 | US20070178094 Autoimmune diseases; antitumor agents; antiallergens; enhancing the immune response of an individual to a specific molecule, by enhancing the MHC class II presentation of an antigenic epitope of the molecule to T lymphocytes of the individual |
08/02/2007 | US20070178086 Monoclonal antibody against ABCA1 |
08/02/2007 | US20070178045 Cyclopeptide derivatives with anti-integrin activity |
08/01/2007 | EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby |
08/01/2007 | EP1813625A1 Method of modulating the profileration of medullary thyroid carcinoma cells |
08/01/2007 | EP1812466A2 Compositions and methods for the control of mammary cell number |
08/01/2007 | EP1812461A2 Molecules which promote hematopoiesis |
08/01/2007 | EP1812035A2 Peptide anti - tumor agent |
08/01/2007 | EP1516184B1 Cell-selective delivery system |
08/01/2007 | EP1332158B1 Peptides, the production and use thereof for binding immunoglobulins |
08/01/2007 | EP0980440B1 Fluorogenic protease substrates based on dye-dimerization |
08/01/2007 | EP0948344B1 Synthetic antibiotics |
08/01/2007 | CN1329397C Cross-linked glycopeptide-cephalosporin antibiotics |
08/01/2007 | CN101010336A Peptide antibiotics and their preparation methods |
08/01/2007 | CN101010335A Methods and compositions for the treatment of gastrointestinal disorders |
08/01/2007 | CN101010096A Cyclic peptides for treatment of cachexia |
08/01/2007 | CN101010095A Cyclic peptides for treatment of cachexia |
08/01/2007 | CN101007845A Method for screening high egg-yield fowl |
08/01/2007 | CN101007844A Synthetic peptides and methods for treating cancer invasion and metastasis |
08/01/2007 | CN101007843A Peptide drug preparation method and application |
08/01/2007 | CN101007842A T4 synthetic product and application thereof |
08/01/2007 | CN101007841A Method for separating and purifying ACE inhibition peptide from rice draff and active peptide obtained therefor |
07/31/2007 | US7250489 Detecting nut allergy |
07/31/2007 | US7250407 For the treatment of disorders associated with dyslipoproteinemia, including cardiovascular disease, atherosclerosis, restenosis, hyperlipidemia, and endotoxemia septic shock |
07/31/2007 | US7250400 Can be used for developing a study of cell attachment activity mediated through various extracellular matrix protein containing beta ig-h3, wound healing, tissue regeneration and metastasis inhibition. |
07/31/2007 | US7250399 Compounds having growth hormone releasing activity |
07/31/2007 | US7250398 Useful as animal feed additives, particularly further containing phytase, xylanase, galactanase, and/or beta-glucanase |
07/31/2007 | US7250397 Antiarrhythmic peptides |
07/31/2007 | CA2240705C Cyclosporin-containing soft capsule preparations |
07/31/2007 | CA2100745C Amylin agonist peptides and uses therefor |